BIOWAVE CORPORATION

BioWave Corporation manufactures FDA-cleared neuromodulation devices for non-invasive pain management and functional recovery. The company specializes in high-frequency peripheral nerve stimulation (HFPNS) technology that delivers therapeutic stimulation directly to pain nerves, blocking pain signal transmission at the source rather than masking surface pain. BioWave's product line includes portable, easy-to-use devices for clinical and home use, complemented by professional in-office procedures. Products include BioWavePRO (professional clinical system), BioWaveHOME (home-use device), BioWaveGO (portable system), BioWavePENS (in-office procedure delivering up to 72 hours of relief in a 30-minute session), and consumable electrodes (noninvasive and percutaneous). Clinical evidence demonstrates meaningful pain reduction, improved mobility and activities of daily living, reduced medication dependency, and high patient satisfaction. The technology is prescribed by the Veterans Administration for tens of thousands of veterans managing chronic and acute pain. BioWave devices are indicated for use in orthopedic, sports medicine, workers' compensation, personal injury, and auto insurance settings. The company serves patients, healthcare providers, sports medicine teams, and distribution partners. Devices are non-surgical, drug-free, and safe for continuous home use with automatic shut-off. Coverage is available through multiple insurance pathways including Workers' Compensation and Personal Injury claims.